| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 152.65B | 152.29B | 177.66B | 127.81B | 141.54B | 163.70B |
| Gross Profit | 18.60B | 17.89B | 22.25B | 17.60B | 21.62B | 29.52B |
| EBITDA | 6.37B | 10.15B | 10.17B | 6.04B | 10.30B | 16.47B |
| Net Income | -94.28M | 215.10M | 2.97B | 421.25M | 4.60B | 6.67B |
Balance Sheet | ||||||
| Total Assets | 168.75B | 167.64B | 174.75B | 161.76B | 145.90B | 154.32B |
| Cash, Cash Equivalents and Short-Term Investments | 27.07B | 25.50B | 22.98B | 21.66B | 18.17B | 16.89B |
| Total Debt | 29.91B | 46.10B | 35.54B | 28.71B | 27.40B | 42.97B |
| Total Liabilities | 100.23B | 104.11B | 106.73B | 97.13B | 83.24B | 97.34B |
| Stockholders Equity | 50.75B | 46.35B | 51.62B | 47.86B | 48.61B | 45.12B |
Cash Flow | ||||||
| Free Cash Flow | 9.51B | 13.72B | 5.70B | -2.77B | 11.06B | 13.89B |
| Operating Cash Flow | 13.55B | 18.32B | 9.26B | 2.70B | 14.62B | 20.57B |
| Investing Cash Flow | -3.07B | -3.75B | -6.63B | -8.17B | -6.26B | -2.84B |
| Financing Cash Flow | -11.96B | -10.25B | -4.24B | 9.71B | -9.76B | -12.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | HK$1.32B | 3.27 | 7.83% | 5.09% | -4.27% | 1.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$982.71M | -14.20 | -1.44% | 14.77% | -15.02% | -65.74% | |
61 Neutral | HK$5.16B | 11.95 | 18.58% | 1.81% | 10.34% | 3.37% | |
56 Neutral | HK$47.52B | 26.98 | 9.89% | 1.77% | 16.87% | 113.79% | |
52 Neutral | HK$64.72B | 60.73 | 0.45% | 2.07% | -14.08% | -105.52% |